Case of complete cure for psoriasis achieved through immunological approach
Psoriasis: Complete cure achieved with immunological approachProfessor Park Eun-soo of Soonchunhyang University announces results of Miracell stem cell treatment At the 2022 World Congress of Aesthetic Plastic Surgery (MCAS ASIA) held in Bangkok for three days from September 29th, stem cell company Miracell (CEO Shin Hyun-soon) and plastic surgeon Professor Eun-soo Park (Soonchunhyang University Bucheon Hospital) presented on the results of “stem cell treatment for refractory psoriasis.” Psoriasis is an intractable disease affecting approximately 2% of the global population. While steroid treatment is typically used, most patients experience relapses and remissions, leading to distress. Furthermore, there is ongoing debate within the academic community about whether psoriasis is a skin disease or an immunological disease. In this presentation, Professor Eun-soo Park presented a case of complete psoriasis cure after two intravenous injections of bone marrow stem cells and blood-derived cells from an immunological perspective. Professor Park Eun-soo stated, “The patient presented at this conference had been suffering from psoriasis for six years, and the severe, widespread psoriasis had prevented her from engaging in social activities. However, she was completely cured after autologous stem cell treatment. As psoriasis frequently relapses, we observed the patient’s progress after treatment, and only recently, after a year and six months, were we able to confidently share the results.” This treatment for the intractable skin disease psoriasis utilized Miracell’s advanced stem cell extraction system, Smart Mcell 2, along with the Bonemarrow kit and blood kit, which were used to selectively collect stem cells. Source: Doctors’ Newspaper (http://www.doctorsnews.co.kr)